When We should be Testing, How often and what to Report

  • Raymond C. Bartlett
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 349)

Abstract

This chapter will offer practical suggestions for clinical microbiologists to help establish cost-effective policies for antimicrobial susceptibility testing of bacteria and efficient reporting of information to guide antimicrobial therapy. The cost of antimicrobic therapy greatly exceeds the cost of the bacteriology laboratory. Therefore, the combined efforts of the microbiologist, the pharmacist and the medical staff should be focused on producing information that reduces antimicrobic cost.1 Procedures will be recommended here to minimize the production of clinically unnecessary information and the reporting of excessive data that is potentially confusing to clinicians. The practices described are based on over 30 years of cooperative effort between the Microbiology Laboratory, Pharmacy Services and the Division of Infectious Diseases, Department of Medicine at Hartford Hospital. These efforts have reduced the percentage of antimicrobic cost in our pharmacy budget to about 15%. Nationally it is more typical for 30–50% of pharmacy budgets to be consumed by antimicrobic use.2,3 Further, about 20,000,000 bacterial isolates are subject to antimicrobial susceptibility testing in the nation’s laboratories annually.4 Compared to one other major center of comparable size and volume of testing we perform one fifth the number of antimicrobial susceptibility tests (Table 1). This results largely from controls that we have imposed on the quality of specimens and the extent of testing that is performed.5 Studies have shown that the cost for microbiologic processing in our laboratory is lower than that for conventional processing without controls.6

Keywords

Mixed Culture Medical Staff Antimicrobial Therapy Antimicrobial Susceptibility Coagulase Negative Staphylococcus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L.D. Edwards, S. Levin, R. Balastra, Ordering Patterns and Utilization of Bacteriologic Culture Reports, Arch Intern Med. 132:678–682 (1973).PubMedCrossRefGoogle Scholar
  2. 2.
    S.L. Barriere, Controversies in Antimicrobial Therapy: Formulary Decisions on Third-Generation Cephalosporins, Am J. Hosp Pharm. 43:625 (1986).PubMedGoogle Scholar
  3. 3.
    M.D. Parr, L.A. Hansen, W.W. Waite, Computer Program for Comparing Total Costs of Intravenous Antibiotic Regimens. Am J Hosp Pharm 43:2189 (1986).PubMedGoogle Scholar
  4. 4.
    R. Preissler, Personal CommunicationGoogle Scholar
  5. 5.
    R.C. Bartlett, Cost Containment in Microbiology, Clin Lab Med. 5:761–791 (1985).PubMedGoogle Scholar
  6. 6.
    R.C. Bartlett, C. Rutz, Processing Control and Cost in Bacteriology, Am J Clin Pathol 74:287–296 (1980).PubMedGoogle Scholar
  7. 7.
    A.L. Barry, P.B. Smith, M. Tuck, Cumulative Techniques and Procedures in Clinical Microbiology, Laboratory Diagnosis of Urinary Tract Infections, CUMITECH 2 (1975).Google Scholar
  8. 8.
    R.C. Bartlett, N. Treiber, Clinical Significance of Mixed Bacterial Cultures of Urine, Am J Clin Pathol 82:319–322 (1984).PubMedGoogle Scholar
  9. 9.
    J.M. Swenson, B.C. Hill, C. Thornsberry, Screening Pneumococci for Penicillin Resistance J Clin Microbiol 24:749–752 (1984).Google Scholar
  10. 10.
    D.M. Jones, E.M. Sutcliffe, Meningococci with Reduced Susceptibility to Penicillin, Lancet 335: 863–864 (1989).CrossRefGoogle Scholar
  11. 11.
    J.A. Waitz, G.V. Doern, S.M. Finegold, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grown Aerobically, NCCLS Doc. M7–A2, Vol. 10Google Scholar
  12. 12.
    P.D. Ellner, H.C. Neu, The Inhibitory Quotient: A Method for Interpreting Minimum Inhibitory Concentration Data, JAMA 246:1575.Google Scholar
  13. 13.
    D.J. Damron, J.W. Warren, G.R. Chippendale, Do Clinical Microbiology Laboratories Report Complete Bacteriology in Urine from Patients with Long-Term Urinary Catheters, J Clin Microbiol 24:400–404 (1986).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Raymond C. Bartlett
    • 1
  1. 1.Hartford HospitalHartfordUSA

Personalised recommendations